GLP-1 agonists have been clinically proven to support sustained weight loss and improve overall health for people struggling with their weight
Semaglutide, the active ingredient in Ozempic and Wegovy, works by slowing stomach emptying and signaling fullness to the brain
When estrogen is too low or fluctuating (common during perimenopause/menopause), the body can store more fat, especially around the midsection, and insulin sensitivity can decline, which may slow weight loss progress even with GLP-1s
In March of 2024, an additional indication was approved by the FDA: to lower the risk of major cardiovascular events in adults with known heart disease and obesity or overweight
If thats true, then every woman who is on Ozempic should at the same time pursue a program that supports production of her bodys natural GLP-1
Using the Wrong Water: Using tap water is unthinkable (it's full of impurities and microorganisms)